Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-034372
Filing Date
2024-08-29
Accepted
2024-08-29 16:05:17
Documents
1
Period of Report
2024-08-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4451
  Complete submission text file 0001493152-24-034372.txt   5903
Mailing Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606
Business Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606 (813) 864-2562
Telomir Pharmaceuticals, Inc. (Issuer) CIK: 0001971532 (see all company filings)

EIN.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address MIRA PHARMACEUTICALS, INC. 1200 BRICKELL AVENUE, SUITE 1950 #1183 MIAMI FL 33131
Business Address
MacPherson Edward Clouston (Reporting) CIK: 0002015989 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41952 | Film No.: 241263611